drugset / Trial / NCT02822105
Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose is of this study is to assess the safety and tolerability of three dose levels of H3N2 M2SR influenza vaccine versus placebo delivered intranasally to healthy adult subjects.
Timeline
- Start
- 2016-06
- Primary completion
- 2017-04
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | H3N2 M2SR monovalent influenza vaccine | Vaccine | — | Intranasal |